Cart
sales@molnova.com
AU-224
CAS No. 287399-47-7
AU-224( —— )
Catalog No. M33244 CAS No. 287399-47-7
AU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAU-224
-
NoteResearch use only, not for human use.
-
Brief DescriptionAU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.
-
DescriptionAU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
-
In Vitro——
-
In VivoAU-224 has excellent effect of promoting digestive motion while showing little side effect and can be orally administered. AU-224 shows only weak gastrointestinal prokinetic activity after oral administration due to its low lipophilicity.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number287399-47-7
-
Formula Weight397.9
-
Molecular FormulaC19H28ClN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCCCC)CN1CCC(NC(=O)C=2C=C(Cl)C(N)=CC2OC)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WO/2000/046201A1
molnova catalog
related products
-
sHNG, [Gly14] - HN, ...
(Gly14)-Humanin (human) (14-Glycine-Humanin (human)) is an analog of Humanin in which the 14th amino acid serine was replaced with glycine (Gly). (Gly14)-Humanin (human) has anti-apoptotic and neuroprotective functions.
-
JNJ-31020028
JNJ-31020028 is a selective brain penetrant antagonist of neuropeptide Y2 receptor with high affinity(pIC50=8.07, human; pIC50=8.22 rat).
-
4-Hydroxy-L-phenylgl...
4-Hydroxy-L-(+)-2-phenylglycine is a carnitine palmitoyltransferase-1 inhibitor. 4-Hydroxy-L-(+)-2-phenylglycine improves whole-body glucose tolerance and insulin sensitivity in high-fat diet-induced obese mouse with insulin resistance.
